NewTimeSpace News: Chengdu Expressway announced on 15 July that Chengwenqiong Expressway Company, its wholly-owned subsidiary, entered into a YZ section procurement contract for precast concrete components with Chengdu Chengtou Urban Construction. The contracted price stands at around RMB 234 million (tax inclusive) for the Chengdu-Wenjiang-Qionglai Expressway Expansion Project.
NewTimeSpace News: On 15 July, Prinx Chengshan announced that Mr. Che Baozhen, Executive Director and Chief Executive Officer, will resign as CEO with effect from 1 August. On the same date, Mr. Jiang Xizhou, Executive Director and Chief Operating Officer, was appointed as President.
NewTimeSpace News: On 15 July, Fameglow Holdingsannounced that its indirectly wholly-owned subsidiary has signed a technology development agreement with Hongkong Sunseeker Technology Limited, entrusting the latter to build an anti-aging and health management platform based on AI models.
NewTimeSpace News: On 15 July, Zhongtai Futures announced that the Group expects its net profit attributable to shareholders for the six months ended 30 June 2026 to grow by approximately 190% to 210% compared with the same period in 2025.
NewTimeSpace News: On 15 July, InnoCare Pharma Limitedannounced that Soficitinib (ICP-332), a new-generation oral TYK2 inhibitor independently developed by the Company, successfully met the primary endpoint in its Phase III registrational clinical trial for the treatment of moderate-to-severe atopic dermatitis.
NewTimeSpace News: Cinda International Holdings announced on 15 July that the Group expects to record consolidated net profit of approximately HK$32 million to HK$38 million for the six months ended 30 June 2026.
NewTimeSpace News: Beijing Enterprises Holdings announced on 15 July that the Company plans to launch the 1st tranche of its 2026 public offering of sci-tech innovation corporate bonds targeted at professional investors in mainland China, with an issuance scale not exceeding RMB 1 billion.
NewTimeSpace News: Haixi Pharmaceuticals announced on 15 July that Mr. Wang Xinkun, Non-executive Director, resigned due to job transfer, with the resignation taking effect upon the election of a new director at the shareholders’ meeting. The Board nominated Mr. Chen Tingze as a candidate for Executive Director.
NewTimeSpace News: China Medical System Holdingsannounced on 15 July that capsules of CMS-D017, an innovative self-developed complement factor B inhibitor, have obtained the clinical trial approval notice issued by the National Medical Products Administration (NMPA).
NewTimeSpace News: Fosun Pharmaceutical announced on 15 July that its controlling subsidiary Fosun Pharmaceutical Industrial Development (Shenzhen) Co., Ltd. has obtained approval from the NMPA to carry out clinical trials of Injection FXR0906 for the treatment of hypertriglyceridemia.
NewTimeSpace News: Hopefluent Group announced on 15 July that Mr. Li Fuqiang, Non-executive Director, resigned from the position of Non-executive Director with effect from 15 July. On the same date, Ms. Wang Jie was appointed as a Non-executive Director.
NewTimeSpace News: Ascletis Pharma announced on 15 July that the Company has selected a fixed-dose combination (FDC) of ASC48, a first-in-class oral small-molecule GIPR agonist, and ASC30, an oral small-molecule GLP-1R agonist, for clinical development. An Investigational New Drug (IND) application is expected to be submitted to the FDA in the fourth quarter of 2026.
NewTimeSpace News: Huaneng Power International announced on 15 July that the Company has completed the issuance of the 10th tranche of Super & Short-term Commercial Paper (SCP) for 2026, with an issuance principal of RMB 3 billion and a coupon rate of 1.34%.
NewTimeSpace News: HBM Holdings announced on 15 July that the Investigational New Drug (IND) application for HBM7575, a long-acting bispecific antibody targeting TSLP and an undisclosed target, has been approved by the National Medical Products Administration (NMPA) for the treatment of asthma.
NewTimeSpace News: Inkeverse announced on 15 July that the Company has completed the allotment and issue of a total of 387,488,400 subscription shares in two tranches, with net proceeds of approximately HK$328 million.
NewTimeSpace News: CapAllianz Holdings announced on 14 July that the Company proposes to acquire a BODY-MIND wellness training project and prepayments at a total consideration of SGD 3.8 million.
